Biocon Biologics Limited, a subsidiary of Biocon Ltd. (BIOCON), announced that the Company has been again recognized as an Asia IP Elite for 2023 by IAM (Intellectual Asset Management), the world’s biggest IP publication. Biocon Biologics has been awarded this prestigious accolade reserved for a select group of Asia-based corporations and research institutions that are…